Getting heart surgery patients moving sooner may speed recovery
NCT ID NCT07276971
First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times
Summary
This study tested a safe early mobilization plan for 60 patients who had coronary artery bypass surgery. The plan included gentle activities like sitting up, deep breathing, and walking starting the day of surgery. The goal was to see if this approach could reduce dizziness, improve oxygen levels, and shorten hospital stays compared to usual care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Hemodynamic stability, defined as: Resting heart rate \<110/min Mean arterial pressure between 60-110 mmHg Oxygen saturation (SpO₂) \>88% Receiving dopamine infusion ≤5 mcg/kg/min at the time of enrollment No auditory, speech, or visual impairments No neurological contraindications (e.g., cerebrovascular accident \[CVA\], ataxia, multiple sclerosis \[MS\]) No orthopedic contraindications that prevent mobilization (e.g., fractures or sequelae) Provided informed consent to participate in the study Age ≥18 years Able to speak Turkish Literate patients Exclusion Criteria: Requirement for intra-aortic balloon pump (IABP) support Postoperative cerebrovascular events High-dose inotropic drug infusion in the early postoperative period: Dopamine ≥10 mcg/kg/min Norepinephrine ≥0.5 mcg/kg/min Concurrent dopamine and norepinephrine infusion Severe arrhythmias preventing mobilization, including: Sinus tachycardia ≥120/min Rapid atrial fibrillation Ventricular tachycardia Ventricular fibrillation Advanced chronic obstructive pulmonary disease (COPD) or bronchiectasis Diagnosed anxiety disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary artery bypass graft are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guven Hospital
Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can heart stent patients go home in 6 hours?
- Can AI read heart scans to predict the next heart attack?
- Can a new drug cool the hidden inflammation that fuels heart disease?
- New CT scanner aims to cut unnecessary heart procedures
- Heart bypass surgeons test which vein layout keeps grafts open
- A soft patch that watches your heart beat in real time